Anika Therapeutics, Inc. Accumulated Other Comprehensive Income
Anika Therapeutics, Inc. (ANIK) had Accumulated Other Comprehensive Income of -$5.33 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-07-29
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$5.33M.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$5.31M.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$4.96M.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$4.94M.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | -$5.33M 10-Q · filed 2026-07-29 |
| 2026-03-31 | -$5.31M 10-Q · filed 2026-04-30 |
| 2025-12-31 | -$4.96M 10-Q · filed 2026-07-29 |
| 2025-09-30 | -$4.94M 10-Q · filed 2025-11-05 |
| 2025-06-30 | -$4.75M 10-Q · filed 2025-07-30 |
| 2025-03-31 | -$6.10M 10-Q · filed 2025-05-09 |
| 2024-12-31 | -$6.78M 10-K · filed 2026-03-03 |
| 2024-09-30 | -$5.70M 10-Q · filed 2024-11-04 |
| 2024-06-30 | -$6.42M 10-Q · filed 2024-08-08 |
| 2024-03-31 | -$6.32M 10-Q · filed 2024-05-08 |
| 2023-12-31 | -$5.94M 10-K · filed 2025-03-17 |
| 2023-09-30 | -$6.56M 10-Q · filed 2023-11-03 |
| 2023-06-30 | -$6.16M 10-Q · filed 2023-08-08 |
| 2023-03-31 | -$6.17M 10-Q · filed 2023-05-09 |
| 2022-12-31 | -$6.44M 10-K · filed 2024-03-15 |
| 2022-09-30 | -$7.50M 10-Q · filed 2022-11-09 |
| 2022-06-30 | -$6.65M 10-Q · filed 2022-08-04 |
| 2022-03-31 | -$5.80M 10-Q · filed 2022-05-06 |
| 2021-12-31 | -$5.72M 10-K · filed 2023-03-16 |
| 2021-09-30 | -$5.32M 10-Q · filed 2021-11-05 |
| 2021-06-30 | -$4.85M 10-Q · filed 2021-08-06 |
| 2021-03-31 | -$5.05M 10-Q · filed 2021-05-07 |
| 2020-12-31 | -$4.54M 10-K · filed 2022-03-11 |
| 2020-09-30 | -$5.30M 10-Q · filed 2020-11-05 |
| 2020-06-30 | -$5.82M 10-Q · filed 2020-08-07 |
| 2020-03-31 | -$6.03M 10-Q · filed 2020-05-22 |
| 2019-12-31 | -$5.90M 10-K/A · filed 2021-04-26 |
| 2019-09-30 | -$6.32M 10-Q · filed 2019-10-28 |
| 2019-06-30 | -$5.70M 10-Q · filed 2019-07-26 |
| 2019-03-31 | -$5.84M 10-Q · filed 2019-05-06 |
| 2018-12-31 | -$5.53M 10-K · filed 2020-03-06 |
| 2018-09-30 | -$5.23M 10-Q · filed 2018-10-26 |
| 2018-06-30 | -$5.12M 10-Q · filed 2018-07-31 |
| 2018-03-31 | -$4.16M 10-Q · filed 2018-05-10 |
| 2017-12-31 | -$4.78M 10-K · filed 2019-02-27 |
| 2017-09-30 | -$5.05M 10-Q · filed 2017-10-27 |
| 2017-06-30 | -$5.74M 10-Q · filed 2017-07-28 |
| 2017-03-31 | -$7.03M 10-Q · filed 2017-05-04 |
| 2016-12-31 | -$7.32M 10-K · filed 2018-02-27 |
| 2016-09-30 | -$6.10M 10-Q · filed 2016-11-01 |
| 2016-06-30 | -$6.41M 10-Q · filed 2016-08-01 |
| 2016-03-31 | -$5.87M 10-Q · filed 2016-05-03 |
| 2015-12-31 | -$6.65M 10-K · filed 2017-02-24 |
| 2014-12-31 | -$4.50M 10-K · filed 2016-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |